Will new clinical trials for Covid-19 give remdesivir a second chance?Ben Valsler introduces the broad-spectrum antiviral that didn't quite make it as the Ebola drug it was originally planned to be.
In this episode, we review the high-yield topic of Cortisol from the Endocrine section. Follow ... Show More